|
41 |
Bioavailability of IgG Administered by the Subcutaneous Route
Enthalten in Journal of clinical immunology Bd. 33, 1.3.2013, Nr. 5, date:7.2013: 984-990
|
|
|
|
42 |
BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification
Enthalten in Stem cell research & therapy Bd. 10, 11.1.2019, Nr. 1, date:12.2019: 1-17
|
|
|
|
43 |
Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: Diagnostic accuracy of visual and semi-quantitative assessment
Enthalten in Journal of cardiovascular magnetic resonance Bd. 14, 28.3.2012, Nr. 1, date:12.2012: 1-9
|
|
|
|
44 |
Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study
Enthalten in BMC psychiatry Bd. 12, 23.10.2012, Nr. 1, date:12.2012: 1-10
|
|
|
|
45 |
Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
Enthalten in BMC pulmonary medicine Bd. 12, 11.12.2012, Nr. 1, date:12.2012: 1-8
|
|
|
|
46 |
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study
Enthalten in BMC neurology Bd. 12, 6.3.2012, Nr. 1, date:12.2012: 1-13
|
|
|
|
47 |
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Enthalten in Nature Communications Bd. 13, 15.6.2022, Nr. 1, date:12.2022: 1-15
|
|
|
|
48 |
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials
Enthalten in BMC medicine Bd. 19, 6.12.2021, Nr. 1, date:12.2021: 1-15
|
|
|
|
49 |
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Enthalten in Journal of translational medicine Bd. 22, 5.3.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
50 |
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
Enthalten in Communications biology Bd. 5, 6.10.2022, Nr. 1, date:12.2022: 1-15
|
|
Administration
